New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, BeovuĀ®, for the treatment of wet age-related macular degeneration (AMD). BeovuĀ® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Medication for Dry Macular Degeneration Coming Soon?

While Wet Macular Degeneration has enjoyed the fruits of great research and effective medications, the more common Dry Macular Degeneration has no similar medications for treatment. That might be changing soon. The company, Allegro Ophthalmics, LLC, has developed the molecule, Risuteganib, which the company states is effective against the oxidative stress in the retina that […]

New implant delivers medicine continuously to eye

The current therapy for treating wet macular degeneration involves costly, frequent injections into the eye. Researchers are currently working on a new therapy that involves putting an implant into the eye that would continuously deliver the medication into the eye. Injection therapy only offers temporary help in preserving central vision with wet macular degeneration and […]

Which medication is best for wet macular degeneration?

Johns Hopkins University School of Medicine researchers studied the ocular as well as systemic effects that three anti-VEGF therapies had on patients. Pegatanib, ranibizumab and bevacizumab were all compared to patients who received no anti-VEGF treatments Researchers evaluated specific studies from databases and focused on 16 randomized controlled trials that had a total of 6347 […]

Revolutionary treatment restores vision

A study that involved a revolutionary treatment using stem cells from the eyes of non-living donors is detailed in STEM CELLS Translational Medicine. Researchers hope that this pioneering treatment may hold the key to finding a cure for blindness that is caused by damage to the cornea. Eight patients with condition known as Limbal stem […]

Gene therapy used to treat AMD

A surgeon at the John Radcliffe Hospital in the UK successfully injected a synthetic gene into a patient’s eye in the hope of stopping the progression of age-related macular degeneration. The patient, Janet Osborne, is the first person to receive the gene therapy in the trial that is being conducted at the John Radcliffe Hospital […]

3D-printed replacement cornea a reality

A new company, Precise Bio, will be creating 3D-printed products for human eyes, including corneas. With almost 10 million people suffering from corneal blindness, these artificially manufactured corneas would greatly reduce the supply limitations that go along with transplant waiting lists. Bioprinters utilize layers of cells and biocompatible materials to print form tissue unlike traditional […]

Implantable Lucentis means fewer injections for wet macular degeneration

Fewer Injections for Wet Macular Degeneration? A tiny implantable device for the treatment of macular degeneration is in clinical trials and may be approved by the FDA. The device will lessen the burden of patients who currently must endure injections on a monthly basis to treat their wet form of macular degeneration. This breakthrough device […]

Seeing Red? Long-term vision problems linked to Viagra

Researchers have found that a high dose of Viagra (sildenafil citrate) can cause retinal damage on a cellular level resulting in color vision problems. Excessive use of the drug could result in long-term vision problems that are potentially irreversible. Study findings were published in the fall issue of Retinal Cases. A study was conducted based […]

Dangers of red eye relieving eyedrops

Most over-the-counter eyedrops used for treating red eyes, contain tetrahydrozoline which is FDA approved for use in the eyes. Some of the brands that contain the chemical are Visine, Murine Plus and Clarine. The labels specifically state that they are for external use only and to keep them out of the reach of children. However, […]